NCT03301181 - Phase 1 Study to Investigate Effect of Rifampin and Itraconazole on the Pharmacokinetics of BGB-3111 in Healthy Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

November 7, 2017

Study Completion Date

November 13, 2017

Conditions

Healthy Volunteers: Asian, Non-Asian

Interventions

DRUG

BGB-3111 (Arm A)

320 mg BGB-3111 single oral dose

DRUG

Rifampin

600 mg rifampin once daily

DRUG

BGB-3111 (Arm B)

Up to 80 mg BGB-3111 single oral dose

DRUG

Itraconazole

200 mg itraconazole once daily

Trial Locations (1)

West Coast Clinical Trials (WCCT), Cypress